# EDGAR Filing Document

**Accession Number:** 0001571934
**File Stem:** 0001104659-25-068559
**Filing Date:** 2025-7
**Character Count:** 9129
**Document Hash:** f1760d159b27ae0925a985ead4ac1223
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-068559.hdr.sgml**: 20250717

**ACCESSION NUMBER**: 0001104659-25-068559

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250717

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250717

**DATE AS OF CHANGE**: 20250717

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TAO Synergies Inc.
- **CENTRAL INDEX KEY:** 0001571934
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 461585656
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40458
- **FILM NUMBER:** 251129047

**BUSINESS ADDRESS:**
- **STREET 1:** 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036
- **BUSINESS PHONE:** 9732420005

**MAIL ADDRESS:**
- **STREET 1:** 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10036

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Synaptogenix, Inc.
- **DATE OF NAME CHANGE:** 20201210

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NEUROTROPE BIOSCIENCE, INC.
- **DATE OF NAME CHANGE:** 20130312

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 17, 2025

**TAO Synergies Inc.**

(Exact name of registrant as specified in its charter)

<u>Delaware</u> <u>001-40458</u> <u>46-1585656</u> <br> (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

1185 Avenue of the Americas, 3<sup>rd</sup> Floor

New York, New York 10036

(Address of principal executive offices and zip code)

Registrant's telephone number, including area code: (973) 242-0005

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see* General Instruction A.2. below):

◻ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

◻ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

◻ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

◻ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading <br> Symbol(s)** | **Name of each exchange on which<br> registered** |
| Common Stock, $0.0001 par value per share | TAOX | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company. ⌧

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

**Item 7.01. Regulation FD.**

On July 17, 2025, TAO Synergies Inc. (the "Company") issued a press release announcing its acquisition of TAO tokens as part of its digital asset treasury strategy directed toward TAO. A copy of the press release is attached as Exhibit 99.1 hereto.

The information in this Item 7.01 to this Current Report on Form 8-K, and in Exhibit 99.1 furnished herewith, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.

**Item 8.01. Other Events.**

On July 17, 2025, the Company announced aggregate purchases to date of 29,899 TAO tokens totaling approximately $10 million.

**Item 9.01. Financial Statements and Exhibits.**

**(d) Exhibits**

---

| | |
|:---|:---|
| **<u>Exhibit</u>** | **<u>Description</u>** |
| [99.1](tm2520114d1_ex99-1.htm) | [Press Release dated July 17, 2025](tm2520114d1_ex99-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

**TAO SYNERGIES INC.**

---

| | | |
|:---|:---|:---|
| Date: July 17, 2025 | By: | /s/ Robert Weinstein |
|  | Name: | Robert Weinstein |
|  | Title: | Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

**TAO Synergies Acquires $10 Million of Bittensor (TAO) to Become<br> Largest Publicly Traded Pure Play TAO Holder**

**29,899 TAO tokens purchased to date**

**Stakes tokens in decentralized AI network for yield generation**

NEW YORK, July 17, 2025 – TAO Synergies Inc. (Nasdaq: TAOX) (the "Company"), a digital asset treasury company focused on Bittensor (TAO), the premier crypto token for decentralized artificial intelligence (AI), today announced that as of July 17, 2025, it has acquired 29,899 TAO tokens for a total purchase price of $10.0 million, at an average price of approximately $334 per token. The purchases of TAO are in accordance with the Company's digital asset treasury strategy directed toward TAO, the native token for Bittensor, a decentralized AI network that incentivizes the development of machine intelligence.

TAO Synergies is now the largest publicly traded pure play TAO holder worldwide.

"We're pleased with how we've positioned our initial $10 million in TAO purchases, having established our holdings at what we believe to be an attractive entry point relative to current market levels. We will continue to purchase TAO tokens as part of our ongoing strategy," said Executive Chairman Joshua Silverman. "Our conviction in TAO is driven by the expected continued growth and expansion of decentralized AI, which is gaining significant traction as a portion of total AI spend. We believe that decentralized AI has the potential to eventually surpass centralized AI."

"Decentralized AI and TAO reminds me of the Internet in 1996 or Bitcoin in 2013/2014. Decentralized AI is still in early days, but accelerated growth is expected as adopters seek the strong near- and long-term benefits," said James Altucher, digital asset treasury strategist for TAO Synergies. "Spending on decentralized AI, and TAO in particular, is rising rapidly as investors seek exposure to the next phase of AI infrastructure growth."

Traditional AI is dominated by centralized tech giants and expensive proprietary models, while access to GPUs is becoming increasingly costly and constrained as AI systems grow more complex. In contrast, decentralized AI networks offer scalable, open participation through token-based incentive, drawing a growing share of AI investment capital.

TAO Synergies is committed to providing transparent updates on treasury holdings and yields periodically in press releases, events and 10-Q and 10-K filings with the SEC.

**About TAO Synergies**

TAO Synergies Inc. is the first pure-play public company focused on the convergence between cryptocurrency and artificial intelligence. The Company's differentiated cryptocurrency treasury strategy is centered exclusively on the acquisition of TAO, the native cryptocurrency of Bittensor, a decentralized blockchain network for machine learning and AI. TAO Synergies Inc. seeks to stake TAO for revenue generation and capital appreciation, a strategy that underscores its mission to create significant value for shareholders.

Further information is available at <u>taosynergies.com</u>.

**Forward-Looking Statements**

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Such forward-looking statements are subject to risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. These and other factors are identified and described in more detail in the Company's filings with the Securities and Exchange Commission. The Company does not undertake to update these forward-looking statements.

**Contact**<br> 800-811-5591<br> <u>ir@taosynergies.com</u>